China Expands Medical Insurance to Cover Oncofertility Preservation, Boosting the IVF Market
(Policy Analysis) The National Healthcare Security Administration (NHSA) has released new guidelines partially covering fertility preservation (egg, sperm, and ovarian tissue cryopreservation) for oncology patients prior to gonadotoxic chemotherapy. Slated to roll out in select pilot provinces in Q3 2026, this marks a significant step towards comprehensive, lifecycle fertility care in China.
Business Insight: This unlocks a highly specialized, state-backed sub-sector: Oncofertility. IVF clinics must rapidly establish direct referral networks with major oncology departments. For equipment suppliers and cryostorage providers at CMTF 2026, this signals a massive incoming demand for long-term, ultra-secure biobanking solutions and automated liquid nitrogen monitoring systems to meet hospital procurement standards.
【Keywords】: #Oncofertility #ChinaIVFMarket #Cryopreservation
【Source】: NHSA Official Announcements / Health News China (Feb 22, 2026)
